Vitamin D levels and presence of AMD are not associated

Article

Recent evidence suggesting a link between low vitamin D levels, delayed angiogenesis and reduced inflammatory response has been disproved.

Recent evidence suggesting a link between low vitamin D levels, delayed angiogenesis and reduced inflammatory response has been disproved in a study featured in Eye.

A cross-sectional clinical study led by Dr S. Golan, Department of Ophthalmology, Tel Aviv Sourasky Medical Center, Israel, looked at 1045 members of the Maccabi Healthcare Services (MHS) with age-related macular degeneration (AMD) and 8124 patients who didn't have AMD. All participants had their Vitamin D levels taken during routine examinations between 2000 and 2008. The main outcome measure was Serum 25-OH vitamin D levels.

The findings demonstrated a mean ±SD level of 25-OH vitamin D of 24.1±9.41 ng/ml for AMD patients and 24.13±9.50 ng/ml for non-AMD patients. A third of AMD patients and 32.86% of the controls had vitamin D levels of under 16 ng/ml, and the proportions of examinations in which the vitamin D level was greater than 74 ng/ml were 0.19 and 0.14%, respectively.

The results suggest the study has disproved a recent investigation into the association between reduced vitamin D levels and presence of AMD.

Recent Videos
David Yorston, FRCS, FRCOphth, discusses his EURETINA keynote lecture
Hoda Shamsnajafabadi, MSc, PhD, presents at the 2024 EURETINA meeting
Timothy L Jackson PhD, MB ChB, FRCOphth, speaks about a combination therapy for VEGF-A/C/D inhibition with sozinibercept and ranibizumab
Carl Awh, MD, FASRS, speaks about the American Society of Retina Specialists (ASRS) at EURETINA
Stefano Mercuri, MD, first author of the winning eposter “Genotype-phenotype correlations in a cohort of genetically determined Retinitis Pigmentosa (RP) Italian patients with Rho gene mutations”
Bahram Bodaghi, MD, PHD, FEBO at the 2024 EURETINA meeting
Enrico Borrelli, MD, FEBO, speaks at EURETINA
Aleksandra Rachitskaya, MD, FASRS, speaks about the Vit-Buckle Society at the 2024 EURETINA Congress.
© 2024 MJH Life Sciences

All rights reserved.